Fibromyalgia syndrome (FMS): Neural therapy as a key to pain reduction and quality of life

Basit Öğe Kaydı
dc.authorid0000-0002-9746-5220
dc.authorid0000-0002-9427-9529
dc.contributor.authorNazlıkul, Hüseyin
dc.contributor.authorUral Nazlıkul, Fatma Gülçin
dc.date.accessioned2025-02-21T12:42:29Z
dc.date.available2025-02-21T12:42:29Z
dc.date.issued2025
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı
dc.description.abstractFibromyalgia syndrome (FMS) is a complex chronic pain disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive impairments. Its global prevalence is estimated at 2–3%, with women between the ages of 30 and 60 being most commonly affected. The pathophysiology of FMS is multifactorial, involving central sensitization processes, dysfunctions of pain inhibition mechanisms, and chronic inflammatory and neuroendocrine disturbances. Pathophysiological Mechanisms: Central sensitization: Increased pain processing in the central nervous system. Neuroendocrine dysfunction: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, altered cortisol and serotonin levels. Lymphatic dysfunction: Edema, inflammation, and accumulation of toxins. Silent inflammation: Chronic inflammatory processes with elevated cytokine activity (e.g., TNF-α, IL-6). Neural Therapy as a Treatment Approach Neural therapy addresses autonomic dysregulation and restores the balance between the sympathetic and parasympathetic nervous systems. Key therapeutic strategies include: Local infiltrations: Procaine or lidocaine injections to reduce pain sensitivity. Segmental therapy: Treatment of spinal reflex zones to regulate the autonomic nervous system. Interference field therapy: Identification and treatment of chronic irritative foci. Adjunctive measures, such as manual lymphatic drainage, anti-inflammatory nutrition, and micronutrient therapy, can enhance treatment efficacy. The combination of neural therapy and regulatory medicine shows promising results in reducing pain, improving sleep quality, and restoring quality of life.
dc.identifier.citationNazlıkul, H., & Ural Nazlıkul, F. G. (2025). Fibromyalgia syndrome (FMS): Neural therapy as a key to pain reduction and quality of life. International Clinical and Medical Case Reports Journal, 4(2), pp. 1-25. https://doi.org/10.5281/zenodo.14843500
dc.identifier.doi10.5281/zenodo.14843500
dc.identifier.endpage25
dc.identifier.issn2832-5788
dc.identifier.issue2
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.5281/zenodo.14843500
dc.identifier.urihttps://hdl.handle.net/20.500.13055/925
dc.identifier.volume4
dc.institutionauthorUral Nazlıkul, Fatma Gülçin
dc.institutionauthorid0000-0002-9427-9529
dc.language.isoen
dc.publisherSalient Visionary Publications LLC
dc.relation.ispartofInternational Clinical and Medical Case Reports Journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCentral Sensitization
dc.subjectNeuroendocrine Dysfunction
dc.subjectSilent Inflammation
dc.subjectAutonomic Dysregulation
dc.subjectInterference Field Therapy and Lymphatic Dysfunction
dc.titleFibromyalgia syndrome (FMS): Neural therapy as a key to pain reduction and quality of life
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
1002.49 KB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Bölümü Koleksiyonu